The biological correlates of macroscopic breast tumour structure measured using fractal analysis in patients undergoing neoadjuvant chemotherapy

Breast Cancer Research and Treatment

Volumn 133, Issue 3, 2012, Pages 1199-1206

  Di Giovanni, P ^a   Ahearn, T S ^a   Semple, S I K ^b   Lovell, L M ^c   Miller, I ^c   Gilbert, F J ^a   Redpath, T W ^a   Heys, S D ^a   Staff, R T ^c  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c ABERDEEN ROYAL INFIRMARY   (United Kingdom)

Author keywords

Breast cancer; Fractal; MRI; Neoadjuvant chemotherapy

Indexed keywords

CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADJUVANT THERAPY; ADULT; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER GROWTH; CANCER PATIENT; CANCER SIZE; CASE REPORT; CONTRAST ENHANCEMENT; FEMALE; FRACTAL ANALYSIS; GEOMETRY; HUMAN; HUMAN TISSUE; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGICAL ANATOMY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; STRUCTURE ANALYSIS; TREATMENT RESPONSE; TUMOR VASCULARIZATION;

ADULT; BREAST NEOPLASMS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; NEOADJUVANT THERAPY; PROGNOSIS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE;

EID: 84863725478     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-012-2014-8     Document Type: Article

References (30)

1. Mandelbrot BB (1983) The Fractal Geometry of Nature. W.H. Freeman, San Francisco
2. George LE, Sager KH (2007) Breast cancer diagnosis using multi-fractal dimension spectra. IEEE international conference on: signal processing and communications, 2007. ICSPC 2007, Dubai, pp 592-595
3. Garra BS, Krasner BH, Horii SC et al (1993) Improving the distinction between benign and malignant breast-lesions-the value of sonographic texture analysis. Ultrason Imaging 15:267-285
4. Byng JW, Boyd NF, Fishell E et al (1996) Automated analysis of mammographic densities. Phys Med Biol 41:909-923
5. Losa GA, Nonnenmacher TF (1996) Self similarity and fractal irregularity in pathologic tissues. Mod Pathol 9:174-182
6. Rose CJ, Mills SJ, O'Connor JPB et al (2009) Quantifying spatial heterogeneity in dynamic contrast-enhanced MRI parameter maps. Magn Reson Med 62:488-499
7. Di Ieva A, Grizzi F, Tschabitscher M et al (2010) Correlation of microvascular fractal dimension with positron emission tomography [(11)C]-methionine uptake in glioblastoma multiforme: preliminary findings. Microvasc Res 80:267-273
8. Jacquemier JD, Penault-Llorca FM, Bertucci F et al (1998) Angiogenesis as a prognostic marker in breast carcinoma with conventional adjuvant chemotherapy: a multiparametric and immunohistochemical analysis. J Pathol 184:130-135
9. Tynninen O, Sjostrom J, von Boguslawski K et al (2002) Tumour microvessel density as predictor of chemotherapy response in breast cancer patients. Br J Cancer 86:1905-1908
10. Semple SIK, Gilbert FJ, Redpath TW et al (2004) The relationship between vascular and metabolic characteristics of primary breast tumours. Eur Radiol 14:2038-2045
11. Semple SIK, Staff RT, Heys SD et al (2006) Baseline MRI delivery characteristics predict change in invasive ductal breast carcinoma PET metabolism as a result of primary chemotherapy administration. Ann Oncol 17:1393-1398
12. Tambasco M, Eliasziw M, Magliocco AM (2010) Morphologic complexity of epithelial architecture for predicting invasive breast cancer survival. J Transl Med 8:140
13. Tofts PS, Berkowitz B, Schnall MD (1995) Quantitative analysis of dynamic Gd-DTPA enhancement in breast tumours using a permeability model. J Magn Reson Med 33:564-568
14. Brix G, Semmler W, Port R et al (1991) Pharmacokinetic parameters in Cns Gd-Dtpa enhanced MR imaging. J Comput Assist Tomogr 15:621-628
15. Hayes C, Padhani A, Leach M (2002) Assessing changes in tumour vascular function using dynamic contrast-enhanced magnetic resonance imaging RID C-2248-2008. NMR Biomed 15:154-163
16. Alic L, Veenland J, van Vliet M et al (2006) Quantification of heterogeneity in dynamic contrast enhanced MRI data for tumor treatment assessment. 2006 3rd IEEE International symposium on biomedical imaging: Macro to Nano, vol 1-3, pp 944-947
17. Yang X, Knopp MV (2011) Quantifying tumor vascular heterogeneity with dynamic contrast-enhanced magnetic resonance imaging: a review. J Biomed Biotechnol 732848
18. Mussurakis S, Gibbs P, Horsman A (1998) Primary breast abnormalities: selective pixel sampling on dynamic gadolinium-enhanced MR images. Radiology 206:465-473
19. Wardlaw G, Wong R, Noseworthy MD (2008) Identification of intratumour low frequency microvascular components via BOLD signal fractal dimension mapping. Physica Med 24:87-91
20. Barrett T, Brechbiel M, Bernardo M et al (2007) MRI of tumor angiogenesis. J Magn Reson Imaging 26:235-249
21. Alvarenga AV, Pereira WCA, Infantosi AFC, Azevedo CM (2007) Classifying breast tumours on ultrasound images using a hybrid classifier and texture features. International symposium on intelligent signal processing, 2007. WISP 2007. IEEE, Alcala de Henares, pp 1-6
22. Risser L, Plouraboue F, Steyer A et al (2007) From homogeneous to fractal normal and tumorous microvascular networks in the brain. J Cereb Blood Flow Metab 27:293-303
23. O'Connor JPB, Rose CJ, Jackson A et al (2011) DCE-MRI bio-markers of tumour heterogeneity predict CRC liver metastasis shrinkage following bevacizumab and FOLFOX-6. Br J Cancer 105:139-145
24. Fisher B, Bryant J, Wolmark N et al (1998) Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. J Clin Oncol 16:2672-2685
25. Smith IC, Heys SD, Hutckeon AW et al (2002) Neoadjuvant chemotherapy in breast cancer: significantly enhanced response with docetaxel. J Clin Oncol 20:1456-1466
26. Leake R (2000) Detection of the oestrogen receptor (ER): immunohistochemical versus cytosol measurements. Eur J Cancer 36:S18-S19
27. Paik S, Bryant J, Tan-Chiu E et al (2002) Real-world performance of HER2 testing-national surgical adjuvant breast and bowel project experience. J Natl Cancer Inst 94:852-854
28. Ogston KN, Miller ID, Payne S et al (2003) A new histological grading system to assess response of breast cancers to primary chemotherapy: prognostic significance and survival. Breast 12: 320-327
29. Hulka B (1996) Epidemiology of susceptibility to breast cancer. Prog Clin Biol Res 395:159-174
30. Semple S, Gilbert F, Redpath T et al (2003) Correlation of MRI/PET rim enhancement in breast cancer: A delivery related phenomenon with therapy implications? Lancet Oncol 4:759